JPMorgan Chase & Co’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69K | Sell |
2,327
-62,509
| -96% | -$45.3K | ﹤0.01% | 5674 |
|
|
2025
Q1 | $55.8K | Sell |
64,836
-81,101
| -56% | -$69.8K | ﹤0.01% | 4999 |
|
|
2024
Q4 | $245K | Buy |
145,937
+110,334
| +310% | +$185K | ﹤0.01% | 4453 |
|
|
2024
Q3 | $101K | Sell |
35,603
-2,014
| -5% | -$5.74K | ﹤0.01% | 4719 |
|
|
2024
Q2 | $88K | Sell |
37,617
-26,384
| -41% | -$61.7K | ﹤0.01% | 4667 |
|
|
2024
Q1 | $188K | Buy |
64,001
+3,403
| +6% | +$10K | ﹤0.01% | 4480 |
|
|
2023
Q4 | $181K | Buy |
60,598
+3,812
| +7% | +$11.4K | ﹤0.01% | 4490 |
|
|
2023
Q3 | $179K | Buy |
56,786
+14,150
| +33% | +$44.7K | ﹤0.01% | 4287 |
|
|
2023
Q2 | $165K | Buy |
42,636
+2,745
| +7% | +$10.6K | ﹤0.01% | 4380 |
|
|
2023
Q1 | $110K | Buy |
39,891
+9,965
| +33% | +$27.5K | ﹤0.01% | 4604 |
|
|
2022
Q4 | $54K | Sell |
29,926
-3,662
| -11% | -$6.61K | ﹤0.01% | 4714 |
|
|
2022
Q3 | $71K | Buy |
33,588
+2,320
| +7% | +$4.9K | ﹤0.01% | 4594 |
|
|
2022
Q2 | $85K | Buy |
31,268
+16,485
| +112% | +$44.8K | ﹤0.01% | 4700 |
|
|
2022
Q1 | $64K | Buy |
14,783
+3,837
| +35% | +$16.6K | ﹤0.01% | 4921 |
|
|
2021
Q4 | $57K | Buy |
+10,946
| New | +$57K | ﹤0.01% | 5028 |
|